동국제약

086450KOSDAQ의약품 제조업

64.7 / 100

Reference Date: 2026-06-10

Financial Score29.5 / 40

News Sentiment19.2 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average and the debt ratio is very low with excellent financial health is also solid. Plunged 23.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Dongkook Pharmaceutical, established in 1968, aims to become South Korea's leading total healthcare group by focusing on new product development and global market expansion. The company offers a wide range of products in over-the-counter drugs, specialty pharmaceuticals, and healthcare sectors, and has successfully exported its products to countries such as China, Japan, and Europe.

Number of Employees

1,306people

Average Salary

67.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

11.92Industry Average 11.935.0Point

In line with industry avg

PBR

1.05Industry Average 0.892.5Point

Higher than industry avg (caution)

ROE

10.25Industry Average 4.017.0Point

2.6x industry avg (excellent)

Debt Ratio

4.16Industry Average 12.436.5Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲12.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲20.2% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 9.7% (improving, 3yr)

Detailed News Sentiment

24 totalPositive 19Neutral 5Negative 0Average Sentiment Score 76.7

Positive
동국제약 센텔리안24, 美 '틱톡샵 K-뷰티 콜렉티브' 참가
동국제약의 센텔리안24가 미국 틱톡샵 K-뷰티 콜렉티브에 참가하여 북미 시장 진출을 확대함으로써 긍정적인 반응을 얻고 있다.
Neutral
KT알파쇼핑, 상반기 결산해보니…'셀프케어' 소비 확산
KT알파쇼핑의 상반기 데이터 분석 결과 '셀프케어' 트렌드가 확인되었으나, 동국제약과 직접적인 연관성이 없다.
Positive
화장품 매출 급증…동국제약 '1조 클럽' 진입 청신호
동국제약의 화장품 브랜드 센텔리안24의 수출 급증으로 매출 목표 달성 기대감이 높아짐.

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 17,730Won52-week high 29,90052-week low 16,420

1-month return0.0Point

1m -23.91% (strong drop)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-05-26
Neutral분기보고서 (2026.03)2026-05-15